Science Explorer Back to mapMap
Discussion
Company · Havlíčkův Brod · Czechia

1 - Cube (Czechia)

1-cube.comROR OpenAlex
Research works
1
▼ 91% vs 2018-21
Citations
33
26.4 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
34%
world 40%
International
100%
world 18%
1 - Cube (Czechia)

Not ranked overall: 1 - Cube (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does 1 - Cube (Czechia) work in?

In all years, 100% of research at 1 - Cube (Czechia) is in Health Sciences. Its largest fields are Medicine (100%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 1 fractional works · 100.0% of its workMedicine: 1 fractional works · 100.0% of its workALL ITS WORK1 - Cube(Czechia)1fractional works, all years
Health Sciences100%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 1 domains and 1 fields, with their numbers
    1. Medicine1100.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from 1 - Cube (Czechia)?

The most cited paper from 1 - Cube (Czechia) is "Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection" (Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez et al., 2014), with 192 citations. Next come "Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles" (43) and "A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol" (26).

Most cited papers
#PaperReleasedCitations
1 Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez et al. · Fertility and Sterility Open access 23 Sep 2014 192
2 Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles Manuel Fernández Sánchez, Hana Višňová, Albert A. Yuzpe et al. · Reproductive BioMedicine Online Open access 23 Dec 2018 43
3 A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol Manuel Fernández Sánchez et al. · Human Reproduction Open access 14 Apr 2022 26
4 Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH ( FE 999049) Ernesto Bosch, Anders Nyboe Andersen, Pedro N. Barri et al. · Clinical Endocrinology Open access 23 Jul 2015 21
5 Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials Georg Griesinger, Christophe Blockeel, Piotr Pierzyński et al. · Human Reproduction 28 Dec 2020 18
All 8 most cited papers, with filters and sorting

Which research topics does 1 - Cube (Czechia) publish most on?

By volume in 2022-now: Ovarian function and disorders, Reproductive Biology and Fertility and Hypothalamic control of reproductive hormones.

  1. 1 Ovarian function and disorders Reproductive Medicine 0 works
  2. 2 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
  3. 3 Hypothalamic control of reproductive hormones Reproductive Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.0%not open66.0%

World: 40% of research is openly available.

with international co-authors100.0%

World: 18% is written across borders.

How has 1 - Cube (Czechia)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

20152020

Other research institutions in Havlíčkův Brod

All research institutions in Havlíčkův Brod

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about 1 - Cube (Czechia). Posts are plain text and can be reported.